Search - tctmd.com

Displaying 381 - 400 of 7110

Sort: Relevancy | Date

Presentation TCT 2016

Mediation Analysis: A Method to Assign Attributable Risk

Presenter: Scott Berry, Stuart J. Pocock, Bjorn Redfors

October 30, 2016

Presentation TCT 2016

Rationale for and Design of ISCHEMIA: What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Jorge Gaspar, Bernard J. Gersh

October 30, 2016

Presentation TCT 2016

Surrogate Endpoints: Construction, Validation, and Trustiness

Presenter: Scott Berry, Stuart J. Pocock, William S. Weintraub

October 30, 2016

Presentation TCT 2016

How to Evaluate and Treat the Patient With Metallic Stent Thrombosis: The Usual Suspects and Beyond

Presenter: Fernando Alfonso, Stephan Windecker, Giulio G. Stefanini

October 30, 2016

Presentation TCT 2016

Accounting for the Risk of Competing Events

Presenter: Scott Berry, Stuart J. Pocock, Peter Juni

October 30, 2016

Presentation TCT 2016

Are All Stent Thromboses Prognostically Created Equal? Impact of Original Clinical Presentation, Stent Location and Thrombosis Timing

Presenter: Fernando Alfonso, Stephan Windecker, Robert-Jan van Geuns

October 30, 2016

Presentation TCT 2016

Rationale for and Design of COMPLETE: What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Jorge Gaspar, Anthony H. Gershlick

October 30, 2016

Presentation TCT 2016

Is the OCT-derived Healing Score A Meaningful Metric to Evaluate Stent Safety?

Presenter: Fernando Alfonso, Stephan Windecker, Giulio Guagliumi

October 30, 2016

Presentation TCT 2016

Analyzing Repeat Events

Presenter: Scott Berry, Stuart J. Pocock, Eugene H. Blackstone

October 30, 2016

Presentation TCT 2016

Rationale and Studies of P2Y12 Inhibitor Monotherapy After DES In Patients In Normal Sinus Rhythm

Presenter: John A. Bittl, Daniel I. Simon, Patrick W. Serruys

October 30, 2016

Presentation TCT 2016

OCT-assessed Rate of Early Strut Coverage: Differences Between DES and Its Implications

Presenter: Fernando Alfonso, Stephan Windecker, Stephen WL Lee

October 30, 2016

Presentation TCT 2016

Case #2 (From Indonesia): Bioresorbable Scaffold for Treatment of Highly-Calcified Diffuse Stenosis: How Did I Treat?

Presenter: Jun-Jack Cheng, Yoshito Yamamoto, Linda Lison

October 30, 2016

Presentation TCT 2016

Limitations of Composite Endpoints and Strategies for Hierarchical Testing

Presenter: Scott Berry, Stuart J. Pocock, Jan G. P. Tijssen

October 30, 2016

Presentation TCT 2016

Is Acute or Late Acquired Malapposition By IVUS or OCT A Risk Factor for Stent Thrombosis?

Presenter: Fernando Alfonso, Stephan Windecker, Gary S. Mintz

October 30, 2016

Presentation TCT 2016

Case #2 (From Indonesia): Bioresorbable Scaffold for Treatment of Highly-Calcified Diffuse Stenosis: Case Introduction

Presenter: Jun-Jack Cheng, Yoshito Yamamoto, Linda Lison

October 30, 2016

Presentation TCT 2016

New Insights Into the Mechanisms and Patterns of in-stent Restenosis in BMS and DES Evaluated By IVUS and OCT (With Case Examples)

Presenter: Fernando Alfonso, Stephan Windecker, Akiko Maehara

October 30, 2016

Presentation TCT 2016

Neoatherosclerosis as A Cause of Very Late DES Failure: Insights From Multimodality Imaging Studies

Presenter: Fernando Alfonso, Stephan Windecker, Yasunori Ueda

October 30, 2016

Presentation TCT 2016

Conclusion and Take-home Message

Presenter: Teguh Santoso, Wasan Udayachalerm

October 30, 2016

Presentation TCT 2016

Can Improvements in Metallurgy and Stent Design Improve Early and Late Outcomes With DES?

Presenter: Fernando Alfonso, Stephan Windecker, Elazer R. Edelman

October 30, 2016

Presentation TCT 2016

Drug-eluting Balloons for Bifurcations in Daily Practice

Presenter: Francesco Burzotta, Dean J. Kereiakes, Goran Stankovic

October 30, 2016

Advertisement

Mediation Analysis: A Method to Assign Attributable Risk

Rationale for and Design of ISCHEMIA: What I Expect the Findings to Be But What Wont Surprise Me!

Surrogate Endpoints: Construction, Validation, and Trustiness

How to Evaluate and Treat the Patient With Metallic Stent Thrombosis: The Usual Suspects and Beyond

Accounting for the Risk of Competing Events

Are All Stent Thromboses Prognostically Created Equal? Impact of Original Clinical Presentation, Stent Location and Thrombosis Timing

Rationale for and Design of COMPLETE: What I Expect the Findings to Be But What Wont Surprise Me!

Is the OCT-derived Healing Score A Meaningful Metric to Evaluate Stent Safety?

Analyzing Repeat Events

Rationale and Studies of P2Y12 Inhibitor Monotherapy After DES In Patients In Normal Sinus Rhythm

OCT-assessed Rate of Early Strut Coverage: Differences Between DES and Its Implications

Case #2 (From Indonesia): Bioresorbable Scaffold for Treatment of Highly-Calcified Diffuse Stenosis: How Did I Treat?

Limitations of Composite Endpoints and Strategies for Hierarchical Testing

Is Acute or Late Acquired Malapposition By IVUS or OCT A Risk Factor for Stent Thrombosis?

Case #2 (From Indonesia): Bioresorbable Scaffold for Treatment of Highly-Calcified Diffuse Stenosis: Case Introduction

New Insights Into the Mechanisms and Patterns of in-stent Restenosis in BMS and DES Evaluated By IVUS and OCT (With Case Examples)

Neoatherosclerosis as A Cause of Very Late DES Failure: Insights From Multimodality Imaging Studies

Conclusion and Take-home Message

Can Improvements in Metallurgy and Stent Design Improve Early and Late Outcomes With DES?

Drug-eluting Balloons for Bifurcations in Daily Practice

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content